APA (7th ed.) Citation

Oubari, S., Papathanasiou, M., Michel, L., Rassaf, T., Thimm, A., Hagenacker, T., . . . Carpinteiro, A. (2025). Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival. Annals of hematology, 104(3), . https://doi.org/10.1007/s00277-025-06256-7

Chicago Style (17th ed.) Citation

Oubari, Sara, et al. "Gain or Amplification of 1q21 in Systemic Light Chain Amyloidosis Is Associated with Advanced Mayo Stage, Plasma Cell Disease and Worse Overall Survival." Annals of Hematology 104, no. 3 (2025). https://doi.org/10.1007/s00277-025-06256-7.

MLA (9th ed.) Citation

Oubari, Sara, et al. "Gain or Amplification of 1q21 in Systemic Light Chain Amyloidosis Is Associated with Advanced Mayo Stage, Plasma Cell Disease and Worse Overall Survival." Annals of Hematology, vol. 104, no. 3, 2025, https://doi.org/10.1007/s00277-025-06256-7.